California Oncology Weekly Newsletter 6.28.2016

California is among about a dozen states considering proposals this year to impose greater price transparency on drug companies. The measures in many states have gone farther than California’s bill, SB 1010 (Hernandez), requiring manufacturers to report their research and development costs, not just the prices and the reasons for them. For more information click here.

Forthcoming Noridian/JEMAC workshops include: Reopenings Workshop (June 29); Recoupment Workshop (June 30); Medicare Secondary Payer Workshop (July 6); Medicare Secondary Payer Calculation Workshop (July 7); NCCI and MUEs Workshop (July 12); Telehealth Services Workshop (July 14); Part B Ask the Contractor Teleconference (July 20). For more information click here.

The California Health Care Foundation (CHCF) recently released a report, “Moving Medi-Cal Forward on the Path to Delivery System Transformation.”  With the 50th anniversary of the Medicaid program happening this year, CHCF contracted with the folks at Manatt Health to explore California’s Medi-Cal program and the best path forward. For more information click here.

A report released Thursday by the Bipartisan Policy Center says that the U.S. should modernize how new drugs are brought to market. “Modernizing the drug discovery, development, and approval of new cures and treatments plays a critical role in addressing this issue and should be a key priority for the United States. It takes too long and costs too much to bring treatments and cures to patients in need…The most reliable studies suggest that on the average it costs approximately $2 billion and takes more than a decade for a new drug to reach the market.” For more information click here.

UPDATE: Starting January 1, 2017 (postponed from July 1, 2016), CMS will require MACs to enforce the following rules for modifier -JW: Modifier JW is required to identify unused drugs or biological from single use vials or single use packages that are appropriately discarded. The only exception to this requirement is when the J-code unit is larger than the drug plus the waste. For more information click here.

To view the complete California Oncology Weekly Newsletter, click on the date below.

June 28, 2016.

California Department of Managed Health Care (DMHC) Director Shelley Rouillard has approved Aetna’s acquisition of Humana.   As a condition of approving the acquisition, the DMHC successfully negotiated several commitments, referred to as “Undertakings,” that will help control health care costs, expand access to care and improve quality of care. For more information click here.

California wants to be the first state in the country to standardize the way cancer data are reported to its central registry, making it faster and easier to collect information from oncology labs.  The effort comes at a time when pathologists have been transitioning from paper-based reporting to electronic data collection. For more information click here.

Forthcoming Noridian/JEMAC workshops include: * Reopenings Workshop (June 29); * Recoupment Workshop (June 30);* Medicare Secondary Payer Workshop (July 6);* Medicare Secondary Payer Calculation Workshop (July 7);* NCCI and MUEs Workshop (July 12). For more information click here.

Oncologists are pushing pediatricians and other providers to help increase use of the HPV vaccine, which studies show could help avert cancer cases during young Americans’ lives. For more information click here.

UPDATE: Starting January 1, 2017 (postponed from July 1, 2016), CMS will require MACs to enforce the following rules for modifier -JW:* Modifier JW is required to identify unused drugs or biological from single use vials or single use packages that are appropriately discarded. For more information click here.

To view the complete California Oncology Weekly Newsletter, click on the date below.

June 21, 2016.

ASCO supports HR5122, legislation that would halt CMS from implementing the CMS Medicare Part B Drug Reimbursement Experiment and help to keep the pressure on the Administration to withdraw or substantially change the Experiment. ANCO and MOASC urge members to contact their Congressional Representatives and ask them to support HR5122. For more information click here.

Under a bill signed Friday, June 10, by Gov. Jerry Brown, California will become the first state to ask federal officials to allow immigrants here illegally to buy insurance through its state health exchange. For more information click here.

Forthcoming CMA webinars include: MACRA and the Quality Payment Program: An Update on the Recent Proposed Rule (June 15). For more information click here.

Noridian’s Provider Outreach and Education Department would like to provide you with their latest news and updates. Currently, top trending items are: The MAC Satisfaction Indicator (MSI) and Revalidat. For more information click here.

The Department of Managed Health Care (DMHC) is seeking a dynamic, creative, and consumer-oriented physician and clinical quality leader to serve as the DMHC Chief Medical Officer (CMO) as a contracted consultant. For more information click here.

To view the complete California Oncology Weekly Newsletter, click on the date below/

June 14, 2016

 

 

MOASC and ANCO encourages all to VOTE today!

THIS THURSDAY, on June 9, California’s End of Life Option Act becomes law. For more information click here.

UnitedHealthcare’s Network Bulletin (June 2016) is now available online; Tools & Resources > News & Network Bulletin and features articles entitled Outreach Efforts to Begin July 1 to Support Care Providers with Continued Adoption of Clinical Data and Submission Protocol. For more information click here.

Noridian/JEMAC has posted the following updates to its website: MLN Connects Provider eNews; Announcements–ICD-10 Resources: Clinical Concepts Series; Claims, Pricers, and Codes–July 2016 Average Sales Price Files Available; Events–Physician Compare Initiative Call-Register Now; Quality Measures and the IMPACT Act Call-Registration Now Open. For more information click here.

DHCS is continuing the development of the PAVE system, which will improve the way providers do business with DHCS’ Provider Enrollment Division (PED) and simplify and expedite the enrollment experience.  The PAVE system will include a provider portal that offers guided preparation, account and affiliations management, real-time status tracking, document storage, e-signatures, and much more.  For more information click here.

Starting July 1, CMS will require MACs to enforce the following rules for modifier -JW : modifier JW is required to identify unused drugs or biologicals from single use vials or single use packages that are appropriately discarded. The only exception to this requirement is when the J-code unit is larger than the drug plus the waste. For more information click here.

Nominations for the ASCO Annual Election are now open and will be accepted through June 12. The open positions are Board of Directors (President-Elect, Designated Community Oncologist, Designated Medical Oncologist, Undesignated Specialty Oncologist) and Nominating Committee (Undesignated Specialty Oncologist). For more information click here. 

To view the complete California Oncology Weekly Newsletter, click on the date below.

June 7, 2016